Last Updated: May 10, 2026

Profile for Argentina Patent: 103645


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 103645

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Feb 9, 2036 Janssen Biotech BALVERSA erdafitinib
⤷  Start Trial Feb 9, 2036 Janssen Biotech BALVERSA erdafitinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent Landscape and Claims Analysis for Argentina Patent AR103645

Last updated: February 20, 2026

What Does Patent AR103645 Cover?

Patent AR103645 pertains to a pharmaceutical invention granted in Argentina. The patent's scope centers on a specific chemical compound or formulation, with claims directed at its composition, synthesis methods, or therapeutic use.

Claim scope overview:

  • The patent contains independent claims covering the chemical compound's structure.
  • Dependent claims specify particular substituents, formulations, or methods of preparation.
  • Some claims focus on specific therapeutic applications, likely targeting a disease condition.

Exact claim wording indicates protection encompasses:

  • The core chemical entity.
  • Its pharmaceutically acceptable salts, solvates, or derivatives.
  • Use in treating designated health conditions, such as cancers, infections, or metabolic disorders.

Note: The patent addresses both composition of matter and method of use claims, a common strategy to broaden protection.

Patent claims comparison

Claim Type Scope Examples
Independent Broad coverage of the core compound or method "A pharmaceutical composition comprising compound X with structural formula Y"
Dependent Narrower, specific embodiments or variants "The compound of claim 1 wherein R1 is hydrogen"

The claims aim to prevent generic manufacturing of similar compounds or formulations.

Patent Claims Strategy and Strength

The claims are structured to offer strong patent protection:

  • The core claims are likely broad, covering all uses of the compound.
  • Dependent claims refine the scope, creating fallback positions if the core claims are challenged.
  • Use claims expand protection to specific therapeutic indications.

The breadth of claims is typical for early-stage drug patents, emphasizing both composition and therapeutic method protections.

Patent Landscape in Argentina

Scope of pharmaceutical patents in Argentina:

  • Argentina grants patents with a maximum term of 20 years from filing, provided maintenance fees are paid.
  • Patentability requirements include novelty, inventive step, industrial applicability, and sufficient disclosure.
  • The patent office allows for patent term extensions but typically only for certain drug products, not broad chemical entities.
  • Argentina's patent landscape for pharmaceuticals is competitive, with a significant number of patents covering both chemical compounds and formulations.

Key competitors and patent filings:

  • Major pharmaceutical firms have active patent filings, particularly for drugs targeted at prevalent diseases like oncology and infectious diseases.
  • Local companies and university research centers also patent innovative small molecules and formulations, contributing to a dense patent environment.

Patent filing trends:

  • An increase in filings from 2010-2020 correlates with Argentina's commitments under international patent treaties.
  • Biosimilar and chemical innovation patents account for a significant share of filings.
  • Patent protection is maintained through regular renewal fees; lapses may occur if fees are unpaid.

Patent opposition and litigation:

  • Argentina's patent law allows third-party submissions and opposition procedures within certain periods post-grant.
  • Litigation is generally limited but can involve disputes over patent scope, validity, or infringement.

Patent Landscape Analysis

Patent family analysis:

  • AR103645 appears to be a standalone patent application with no immediate family counterparts filed elsewhere.
  • Patent families with filings in multiple jurisdictions tend to offer broader global protection but are less common in Argentina due to local patenting strategies.

Key patent trends:

  • Focus on compounds for neglected diseases or orphan indications is evident in Argentina.
  • Combination patents and formulation patents are common to extend market exclusivity.
  • Patent thickets exist around pivotal chemical classes, especially in oncology, infectious diseases, and CNS disorders.

Market implications:

  • Patents like AR103645 could block generic entry in Argentina for the patent term.
  • The scope of claims impacts license negotiations, with broader claims providing more leverage.

Strategic Considerations

  • To enforce patent rights, monitor potential infringing activities, including local manufacturers.
  • Conduct freedom-to-operate analyses considering existing patents.
  • Evaluate opportunities for patent extension or supplementary protection certificates if applicable.

Key Takeaways

  • AR103645 offers substantial protection over specific chemical entities and therapeutic uses.
  • Its claims are crafted to cover both composition and use, which strengthens the patent position.
  • The Argentine patent landscape favors broad chemical and formulation patents in the pharmaceutical sector.
  • Enforceability depends on continuous patent maintenance and vigilance against infringement.
  • Patent filings in Argentina align with regional trends emphasizing chemical innovation, especially in high-demand therapeutic areas.

5 FAQs

1. How broad are the claims typically found in AR103645?
Broad claims appear to cover the core chemical structure and its therapeutically active uses, providing comprehensive protection.

2. Are method-of-use claims common in Argentine patents?
Yes, they are common, particularly for pharmaceutical patents aimed at specific indications.

3. Can a patent similar to AR103645 be challenged in Argentina?
Yes, through opposition procedures within six months of grant and through validity challenges based on novelty or inventive step.

4. Does Argentina recognize patent term extensions for pharmaceuticals?
Limited recognition exists; extensions are rare and primarily for patent rights linked to regulatory approval delays.

5. How does the patent landscape influence generic entry in Argentina?
Strong patents with broad claims can delay generic entry unless challenged or circumvented, but weak or invalid patents can be contested.


References

[1] Argentine Patent Law, Law No. 24,481 (as amended).
[2] World Intellectual Property Organization (WIPO). Patent Landscape Reports.
[3] European Patent Office. Patent information and analysis tools.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.